Veterinary Dermatology Drugs Market, By Type of Drug (Antibiotics, Antifungal drugs, Anti-inflammatory drugs, Immunotherapy drugs, Parasiticides, Others), By Animal Type (Dogs, Cats, Horses, Others), And by Region (North America, Latin America, Europe, As
Veterinary Dermatology Drugs Market, By Type of Drug (Antibiotics, Antifungal drugs, Anti-inflammatory drugs, Immunotherapy drugs, Parasiticides, Others), By Animal Type (Dogs, Cats, Horses, Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.
Market Dynamics:
The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.
On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.
Key features of the study:
This report provides in-depth analysis of the global veterinary dermatology drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary dermatology drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market
Detailed Segmentation:
Global Veterinary Dermatology Drugs Market, By Type of Drug:
Antibiotics
Antifungal drugs
Anti-inflammatory drugs
Immunotherapy drugs
Parasiticides
Others
Global Veterinary Dermatology Drugs Market, By Animal Type:
Dogs
Cats
Horses
Others
Global Veterinary Dermatology Drugs Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Company Profiles:
Zoetis Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Bayer AG
Ceva Sante Animale
Kindred Biosciences, Inc.
IDEXX Laboratories, Inc.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type Of Drug
Market Snapshot, By Animal Type
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Growing prevalence of skin disease in animals
Rise in number of pet owners
Restraints
Lack of awareness across developing countries
Side-effects associated with drugs
Strict approval regulations
Opportunities
Increasing investment by government and private sectors
Development of cutting-edge therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Veterinary Dermatology Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2017-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
Antifungal drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
Anti-inflammatory drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
Immunotherapy drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
Parasiticides
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
6. Global Veterinary Dermatology Drugs Market , By Animal Type, 2017-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Dogs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
Cats
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
Horses
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
7. Global Veterinary Dermatology Drugs Market , By Region, 2017-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2017 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
8. Competitive Landscape
Zoetis Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Elanco Animal Health Incorporated
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Virbac
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Vetoquinol S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Dechra Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ceva Sante Animale
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Kindred Biosciences, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
IDEXX Laboratories, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Veterinary Dermatology Drugs Market” - Global forecast to 2030